advertisement
Williams PA 19
Showing records 1 to 19 | Display all abstracts from Williams PA119007 Glial metabolic alterations during glaucoma pathogenesis
Rombaut A
Frontiers in ophthalmology 2023; 3: 1290465
119792 Intravitreal injection of the Galectin-3 inhibitor TD139 provides neuroprotection in a rat model of ocular hypertensive glaucoma
Rombaut A
Molecular brain 2024; 17: 84
120162 Oral nicotinamide provides robust, dose-dependent structural and metabolic neuroprotection of retinal ganglion cells in experimental glaucoma
Cimaglia G
Acta neuropathologica communications 2024; 12: 137
120564 Peripheral blood mononuclear cell respiratory function is associated with progressive glaucomatous vision loss
Petriti B
Nature Medicine 2024; 30: 2362-2370
119792 Intravitreal injection of the Galectin-3 inhibitor TD139 provides neuroprotection in a rat model of ocular hypertensive glaucoma
Rombaut A
Molecular brain 2024; 17: 84
119007 Glial metabolic alterations during glaucoma pathogenesis
Rombaut A
Frontiers in ophthalmology 2023; 3: 1290465
119792 Intravitreal injection of the Galectin-3 inhibitor TD139 provides neuroprotection in a rat model of ocular hypertensive glaucoma
Brautaset R
Molecular brain 2024; 17: 84
120564 Peripheral blood mononuclear cell respiratory function is associated with progressive glaucomatous vision loss
Rabiolo A
Nature Medicine 2024; 30: 2362-2370
119007 Glial metabolic alterations during glaucoma pathogenesis
Brautaset R
Frontiers in ophthalmology 2023; 3: 1290465
120162 Oral nicotinamide provides robust, dose-dependent structural and metabolic neuroprotection of retinal ganglion cells in experimental glaucoma
Tribble JR
Acta neuropathologica communications 2024; 12: 137
119007 Glial metabolic alterations during glaucoma pathogenesis
Williams PA
Frontiers in ophthalmology 2023; 3: 1290465
120162 Oral nicotinamide provides robust, dose-dependent structural and metabolic neuroprotection of retinal ganglion cells in experimental glaucoma
Votruba M
Acta neuropathologica communications 2024; 12: 137
119792 Intravitreal injection of the Galectin-3 inhibitor TD139 provides neuroprotection in a rat model of ocular hypertensive glaucoma
Williams PA
Molecular brain 2024; 17: 84
120564 Peripheral blood mononuclear cell respiratory function is associated with progressive glaucomatous vision loss
Chau KY; Williams PA
Nature Medicine 2024; 30: 2362-2370
119792 Intravitreal injection of the Galectin-3 inhibitor TD139 provides neuroprotection in a rat model of ocular hypertensive glaucoma
Tribble JR
Molecular brain 2024; 17: 84
120162 Oral nicotinamide provides robust, dose-dependent structural and metabolic neuroprotection of retinal ganglion cells in experimental glaucoma
Williams PA
Acta neuropathologica communications 2024; 12: 137
119007 Glial metabolic alterations during glaucoma pathogenesis
Tribble JR
Frontiers in ophthalmology 2023; 3: 1290465
120162 Oral nicotinamide provides robust, dose-dependent structural and metabolic neuroprotection of retinal ganglion cells in experimental glaucoma
Morgan JE
Acta neuropathologica communications 2024; 12: 137
120564 Peripheral blood mononuclear cell respiratory function is associated with progressive glaucomatous vision loss
Montesano G; Lascaratos G; Garway-Heath DF
Nature Medicine 2024; 30: 2362-2370
